SWP
INO icon

Strategic Wealth Partners’s Inovio Pharmaceuticals INO Stock Holding History

Strategic Wealth Partners’s Portfolio INO Stock Details INO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15 Hold
14
– – ﹤0.01% 1436
2026
Q1 		$24 Sell
14
-15
-52% -$25 ﹤0.01% 1442
2025
Q4 		$50 Hold
29
– – ﹤0.01% 1409
2025
Q3 		$68 Hold
29
– – ﹤0.01% 1285
2025
Q2 		$59 Buy
+29
New +$56 ﹤0.01% 1116

Other funds holding INO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Strategic Wealth Partners's INO Position: Q2 2026 in Review

Strategic Wealth Partners held its Inovio Pharmaceuticals (INO) position steady in Q2 2026 at 14 shares worth $15. The position accounts for ﹤0.01% of the portfolio, ranked #1436.

Strategic Wealth Partners first reported a position in INO in Q2 2025 and has held it in 5 quarters since. The position peaked at $68 in Q3 2025. 103 funds tracked by Wall St. Rank hold INO as of Q2 2026.

  • Strategic Wealth Partners held 14 shares of Inovio Pharmaceuticals worth $15 as of Q2 2026.
  • Strategic Wealth Partners left its Inovio Pharmaceuticals share count unchanged in Q2 2026.
  • Inovio Pharmaceuticals made up ﹤0.01% of Strategic Wealth Partners's portfolio in Q2 2026, its #1436 holding.
  • Strategic Wealth Partners first reported a position in Inovio Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
  • Strategic Wealth Partners's Inovio Pharmaceuticals position peaked at $68 in Q3 2025.
  • 103 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q2 2026.

Based on Strategic Wealth Partners's 13F filing for Q2 2026, filed 12 Aug 2026.